Ivana Ljubičić Bistrović

Ivana Ljubičić Bistrović

Auto-generated profile, based on publicly available information

Ivana Ljubičić Bistrović

Department of Psychiatry, University Hospital Centre Rijeka, Rijeka, Croatia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in The Canadian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
DLDulijano Ljubicic
Dulijano Ljubicic
MCMarina Letica Crepulja
Marina Letica Crepulja
Dinko VitezicDinko Vitezic
Dinko Vitezic
IBIvana Ljubicic Bistrovic
Ivana Ljubicic Bistrovic
RLRudolf Ljubicic
Rudolf Ljubicic
Objective: To review the feasibility and effectiveness of single daily dosing of lithium in patients with affective disorder and to discuss advantages and disadvantages of this schedule of administration. Method: A comprehensive search of the literature was conducted using a combination of electronic databases and a search of reference lists and relevant journals. English-language articles were selected for the review if they discussed the issues comparing multiple and single daily dosing schedules of lithium. Results: We found 9 comparative studies. Single daily dosing of lithium causes transient higher peak lithium concentrations; however, no comparative study revealed a significant difference in side effects between multiple and single daily dosing groups. Numerous reports concluded that taking lithium in a single dose prevents, or at least limits, the increase in urine output (and the reduction of osmolality) and subsequent thirst. There is no evidence that a single lithium dosing schedule preserves glomerular function. Conclusion: According to the presented data, it could be reasonable to use lithium as a single evening dose in patients who can tolerate this schedule because no studies have suggested any benefit from administration of multiple daily doses. Possible advantages of single daily dosing, especially in improved compliance, could not be veiled by disadvantages of transient and mild postabsorptive side effects.

1 December 2012
Verified
Journal Article
Closed access
IBIvana Ljubičić Bistrović
Ivana Ljubičić Bistrović
IRIka Roncević-Grzeta
Ika Roncević-Grzeta
ZCZeljka Crncević-Orlić
Zeljka Crncević-Orlić
TFTanja Francisković
Tanja Francisković
RLRudolf Ljubicić
Rudolf Ljubicić
MKMiljenko Kapović
Miljenko Kapović

1 December 2013
Verified
Journal Article
Closed access
RLRudolf Ljubicic
Rudolf Ljubicic
HJHrvoje Jakovac
Hrvoje Jakovac
IBIvana Ljubičić Bistrović
Ivana Ljubičić Bistrović
TFTanja Franceski
Tanja Franceski
AMAna Kovak Mufić
Ana Kovak Mufić
DKDalibor Karlović
Dalibor Karlović

1 December 2016
Verified
Journal Article
Closed access
KKKarin Kuljanić
Karin Kuljanić
TDTamara Martinac Dorčić
Tamara Martinac Dorčić
IBIvana Ljubičić Bistrović
Ivana Ljubičić Bistrović
ABAlemka Brnčić-Fischer
Alemka Brnčić-Fischer

1 December 2002
Verified
Journal Article
Closed access
IBIvana Ljubičić Bistrović
Ivana Ljubičić Bistrović
DLDulijano Ljubicić
Dulijano Ljubicić
DEDarko Ekl
Darko Ekl
LPLjubomir Penezić
Ljubomir Penezić
DMDejvis Mocenić
Dejvis Mocenić
MSMarin F Stancić
Marin F Stancić

1 September 2010
Verified
Journal Article
Closed access
RLRudolf Ljubicić
Rudolf Ljubicić
VPVjekoslav Peitl
Vjekoslav Peitl
IBIvana Ljubicić Bistrović
Ivana Ljubicić Bistrović
LGLea Gudelj
Lea Gudelj
DLDulijano Ljubicić
Dulijano Ljubicić
MPMarija Vucić Peitl
Marija Vucić Peitl